BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33109431)

  • 1. Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
    Jang TY; Wei YJ; Yeh ML; Liu SF; Hsu CT; Hsu PY; Liu TW; Lin YH; Liang PC; Hsieh MH; Ko YM; Tsai YS; Chen KY; Lin CC; Tsai PC; Wang SC; Huang CI; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Huang CF; Yu ML
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):303-310. PubMed ID: 33109431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
    Jang TY; Ho CC; Wu CD; Dai CY; Chen PC
    Medicine (Baltimore); 2023 Oct; 102(43):e34276. PubMed ID: 37904402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
    Jang TY; Wei YJ; Liu TW; Yeh ML; Liu SF; Hsu CT; Hsu PY; Lin YH; Liang PC; Hsieh MH; Ko YM; Tsai YS; Chen KY; Lin CC; Tsai PC; Wang SC; Huang CI; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Huang CF; Yu ML
    Sci Rep; 2021 Apr; 11(1):8184. PubMed ID: 33854160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial serologic changes of hepatitis D virus in chronic hepatitis B patients receiving nucleos(t)ides analogues therapy.
    Jang TY; Wei YJ; Hsu CT; Hsu PY; Liu TW; Lin YH; Liang PC; Hsieh MH; Ko YM; Tsai YS; Chen KY; Lin CC; Tsai PC; Wang SC; Huang CI; Yeh ML; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Huang CF; Yu ML
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1886-1892. PubMed ID: 32247291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical course and outcomes of chronic viral hepatitis D in patients from Republic of Tuva as endemic region].
    Isaeva OV; Il'chenko LY; Saryglar AA; Karlsen AA; Kyuregyan KK; Mikhailov MI
    Vopr Virusol; 2021 Mar; 66(1):74-83. PubMed ID: 33683068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D.
    Schaper M; Rodriguez-Frias F; Jardi R; Tabernero D; Homs M; Ruiz G; Quer J; Esteban R; Buti M
    J Hepatol; 2010 May; 52(5):658-64. PubMed ID: 20346531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis.
    Hoan NX; Hoechel M; Tomazatos A; Anh CX; Pallerla SR; Linh LTK; Binh MT; Sy BT; Toan NL; Wedemeyer H; Bock CT; Kremsner PG; Meyer CG; Song LH; Velavan TP
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33671832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, China.
    Liao B; Zhang F; Lin S; He H; Liu Y; Zhang J; Xu Y; Yi J; Chen Y; Liu H; Wang Z; Cai W
    PLoS One; 2014; 9(12):e115888. PubMed ID: 25532128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective study.
    Wei S; Hu M; Chen H; Xie Q; Wang P; Li H; Peng J
    BMC Gastroenterol; 2022 Aug; 22(1):387. PubMed ID: 35978283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees.
    Engle RE; De Battista D; Danoff EJ; Nguyen H; Chen Z; Lusso P; Purcell RH; Farci P
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Zukeran H
    J Med Virol; 2001 Nov; 65(3):478-84. PubMed ID: 11596082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entecavir treatment of chronic hepatitis D.
    Kabaçam G; Onder FO; Yakut M; Seven G; Karatayli SC; Karatayli E; Savas B; Idilman R; Bozdayi AM; Yurdaydin C
    Clin Infect Dis; 2012 Sep; 55(5):645-50. PubMed ID: 22573857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation of hepatitis D in Pakistani children.
    Abbas Z; Soomro GB; Hassan SM; Luck NH
    Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1098-103. PubMed ID: 25089545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and predictive value of HBcrAg, HBV RNA and anti-HBc during bulevirtide treatment of chronic HDV-infected patients.
    Sandmann L; Deterding K; Bremer B; Port K; Cornberg M; Wedemeyer H; Maasoumy B
    J Viral Hepat; 2023 Apr; 30(4):283-286. PubMed ID: 36648369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction.
    Wu JC; Chen TZ; Huang YS; Yen FS; Ting LT; Sheng WY; Tsay SH; Lee SD
    Gastroenterology; 1995 Mar; 108(3):796-802. PubMed ID: 7875481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus.
    Kiesslich D; Crispim MA; Santos C; Ferreira Fde L; Fraiji NA; Komninakis SV; Diaz RS
    J Infect Dis; 2009 Jun; 199(11):1608-11. PubMed ID: 19388852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.